SOTERA HEALTH COMPANY Other Noncash Income (Expense)
SOTERA HEALTH COMPANY (SHC) reported Other Noncash Income (Expense) of $2.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-06
- SOTERA HEALTH COMPANY other noncash income (expense) for the quarter ending 2026-06-30 was $914.00K, a 9.15% decline year-over-year.
- SOTERA HEALTH COMPANY other noncash income (expense) for the quarter ending 2026-03-31 was $1.66M, a 12.81% increase year-over-year.
- SOTERA HEALTH COMPANY other noncash income (expense) for the quarter ending 2025-12-31 was $526.00K, a 51.83% decline year-over-year.
- SOTERA HEALTH COMPANY other noncash income (expense) for the quarter ending 2025-09-30 was $1.27M, a 25.37% increase year-over-year.
- SOTERA HEALTH COMPANY other noncash income (expense) for fiscal 2025 was $4.28M, a 20.35% decline from fiscal 2024.
- SOTERA HEALTH COMPANY other noncash income (expense) for fiscal 2024 was $5.37M, a 0.90% increase from fiscal 2023.
- SOTERA HEALTH COMPANY other noncash income (expense) for fiscal 2023 was $5.32M, a 23.89% decline from fiscal 2022.
- SOTERA HEALTH COMPANY other noncash income (expense) for fiscal 2022 was $6.99M, a 45.09% decline from fiscal 2021.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $914.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.57M 10-Q · filed 2026-08-06 | $3.10M derived: sum of 3 quarters · filed 2026-08-06 | $4.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.66M 10-Q · filed 2026-05-05 | $2.18M derived: sum of 2 quarters · filed 2026-05-05 | $3.46M derived: sum of 3 quarters · filed 2026-05-05 | $4.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $526.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.80M derived: sum of 2 quarters · filed 2026-02-24 | $2.81M derived: sum of 3 quarters · filed 2026-08-06 | $4.28M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.28M derived: sum of 2 quarters · filed 2026-08-06 | $3.75M 10-Q · filed 2025-11-04 | $4.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.47M 10-Q · filed 2026-08-06 | $3.57M derived: sum of 3 quarters · filed 2026-08-06 | $4.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.47M 10-Q · filed 2026-05-05 | $2.56M derived: sum of 2 quarters · filed 2026-05-05 | $3.58M derived: sum of 3 quarters · filed 2026-05-05 | $5.84M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.11M derived: sum of 2 quarters · filed 2026-02-24 | $4.37M derived: sum of 3 quarters · filed 2026-02-24 | $5.37M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.28M derived: sum of 2 quarters · filed 2025-11-04 | $4.28M 10-Q · filed 2025-11-04 | $6.10M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $3.26M 10-Q · filed 2025-08-08 | $5.08M derived: sum of 3 quarters · filed 2026-02-24 | $5.95M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $998.00K 10-Q · filed 2025-05-01 | $2.83M derived: sum of 2 quarters · filed 2026-02-24 | $3.69M derived: sum of 3 quarters · filed 2026-02-24 | $4.99M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.70M derived: sum of 2 quarters · filed 2026-02-24 | $3.99M derived: sum of 3 quarters · filed 2026-02-24 | $5.32M 10-K · filed 2026-02-24 |
| 2023-09-30 | $869.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $2.16M derived: sum of 2 quarters · filed 2024-11-05 | $3.49M 10-Q · filed 2024-11-05 | $4.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $2.62M 10-Q · filed 2024-08-05 | $3.50M derived: sum of 3 quarters · filed 2025-02-27 | $5.57M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.33M 10-Q · filed 2024-05-02 | $2.21M derived: sum of 2 quarters · filed 2025-02-27 | $4.27M derived: sum of 3 quarters · filed 2025-02-27 | $6.33M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $880.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.95M derived: sum of 2 quarters · filed 2025-02-27 | $5.00M derived: sum of 3 quarters · filed 2025-02-27 | $6.99M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $4.12M derived: sum of 2 quarters · filed 2023-11-01 | $6.11M 10-Q · filed 2023-11-01 | $12.66M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.04M 10-Q · filed 2023-08-03 | $10.60M derived: sum of 3 quarters · filed 2024-02-27 | $12.53M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $1.99M 10-Q · filed 2023-05-03 | $8.54M derived: sum of 2 quarters · filed 2024-02-27 | $10.48M derived: sum of 3 quarters · filed 2024-02-27 | $11.87M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $8.49M derived: sum of 2 quarters · filed 2024-02-27 | $9.88M derived: sum of 3 quarters · filed 2024-02-27 | $12.73M 10-K · filed 2024-02-27 |
| 2021-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $3.33M derived: sum of 2 quarters · filed 2022-11-02 | $6.17M 10-Q · filed 2022-11-02 | $6.61M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.24M 10-Q · filed 2022-08-04 | $4.68M derived: sum of 3 quarters · filed 2023-02-28 | $6.07M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $2.84M 10-Q · filed 2022-05-05 | $3.28M derived: sum of 2 quarters · filed 2023-02-28 | $4.67M derived: sum of 3 quarters · filed 2023-02-28 | $6.07M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.83M derived: sum of 2 quarters · filed 2023-02-28 | $3.23M derived: sum of 3 quarters · filed 2023-02-28 | $5.54M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.79M derived: sum of 2 quarters · filed 2021-11-10 | $5.10M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $3.70M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $2.31M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $5.22M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |